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Abstract
Background: The etiology of Autoimmune chronic uveitis (ACU) is still unknown; NOD2/CARD15 gene mutations
are responsible for the Blau Syndrome and can induce uveitis in animal models.
Presentation of the hypothesis: Aim of our study was to assess if NOD2/CARD15 variants have a role in the
etiology or in the clinical course of patients with ACU, either idiopathic or associated with other inflammatory
diseases.
Testing the hypothesis: We consecutively enrolled 25 patients (19 pediatric and 6 adults) affected with ACU. For
each patient medical history was reviewed and clinical data were recorded. Allelic and genotypic frequencies of
NOD2/CARD15 variations were calculated in patients and matched with those of 25 healthy controls. The statistical
analysis was performed.
Fifteen patients showed the polymorphism P268S/SNP5 (SNP rs2066842) as heterozygous carriers while two
patients were homozygous for the same polymorphism; one patient carried also the variant c647 18–16 TCT on
intron 3, not previously reported in the literature. Statistical analysis for NOD2/CARD15 genotyping showed
significant differences between patients and controls for allelic frequencies (p = 0.04, OR: 4.03, 95 %; CI = 1.2–13.5)
but not for genotypic frequencies. We could not identify a significant phenotype-genotype correlation.
Implications of the hypothesis: In our cohort of Italian patients, the NOD2/CARD15 common variant P268S/SNP5
could potentially be significantly associated with ACU.
Keywords: Paediatric uveitis NOD2/CARD15, Inflammatory eye disease, Intra-ocular inflammation, Chronic
autoimmune uveitis, Blau syndrome
Background
The term “non-infectious uveitis” encompasses a group of
heterogeneous conditions characterized by an inflamma-
tory process affecting both the uveal tract and the adjacent
structures; the intra-ocular inflammation can complicate
the clinical course of various autoimmune disorders,
mainly Juvenile Idiopathic Arthritis, or can arise de novo
and be limited to the eye (idiopathic uveitis) [1]. The
current classification of Autoimmune Chronic Uveitis
(ACU) is based on the anatomical localization of the
inflammation and classify uveitis as anterior, intermediate,
posterior and panuveitis [2].
Although ACU is considered a rare disorder, clinicians
should not overlook it; indeed this condition is potentially
sight-threatening and represents one of the most common
causes of legal blindness in the developed countries.
Patients affected by uveitis often experience relapses and
complications and require long term immunosuppressive
therapy and a multidisciplinary approach [3].
The pathogenesis of intra-ocular inflammation is still
unknown, but genetic factors may have a key role in the
susceptibility to some uveitis entities; therefore several
studies have investigated the genetic causes of uveitis
and numerous genes, involved in both innate and adap-
tive immune responses, have been studied [4, 5].
The Caspase recruitment domain gene CARD15 ap-
pears to play an important role in regulating inflamma-
tory responses against bacteria [6]; it encodes the NOD2
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receptor which is a member of the pattern recognition
receptors (PRRs) family, is expressed mainly in the cyto-
plasm of monocytes and APCs (antigen presenting cells)
and can detect intracellular pathogens.
Both members of the NOD family (NOD1 and NOD2)
are composed of three domains: a C-terminal leucine-
rich repeat (LRR) domain involved in ligand recognition,
a central nucleotide binding oligomerization domain
(NOD) with ATPase-mediated self-oligomerization cap-
acity, and an N-terminal CARD domain.
The role of the NOD2/CARD15 gene in ACU is particu-
larly intriguing: certain mutations (mainly R334W, R334Q
and L469F) alter the NOD domain of the receptor, in-
crease the activity of the NF-kB pathways and cause a rare
autosomal dominant inflammatory disease, named “Blau
Syndrome”, which is characterized by early-onset granu-
lomatous arthritis, dermatitis and recurrent uveitis [7].
On the other hand, other mutations of this gene,
affecting the leucine-rich repeat domain of the protein,
have been associated with an increase susceptibility to
Crohn's Disease, a granulomatous inflammatory disease
affecting the gastrointestinal tract and complicated by
uveitis in the 5–10 % of all patients [8].
Presentation of the hypothesis
The role of NOD2/CARD15 gene as a key regulator of
innate immunity in the eye has been elucidated by stud-
ies performed on murine models,which are knockout for
NOD2/CARD15, which showed an increased susceptibil-
ity to uveitis [9, 10]. However the first reports conducted
on patients affected by idiopathic uveitis has failed to
demonstrate a role for this gene in this disease; two stud-
ies conducted on a large cohort of spanish patients with
idiopathic uveitis suggested that NOD2/CARD15 variants
do not seem to predispose to thee disease [11, 12]. In
order to investigate the possible role of this gene in ACU,
we have studied NOD2/CARD15 variants and the
genotype-phenotype correlation in a cohort of patients




Twenty-five unrelated Italian patients with an established
diagnosis of ACU have been included in the present study:
the population was composed of 19 pediatric and 6 adults.
Patients were consecutively enrolled in 2012–2013 at
paediatric hospital “Anna Meyer” (Florence, Italy) and at
Hospital “Santa Maria alle Scotte” (Siena, Italy). Inclusion
criteria were the presence of ACU and willingness to par-
ticipate in the study. Written consent was obtained by all
adult patients or guardians. Data regarding age of onset,
type and localization of uveitis, associated diseases, and
complications were collected and recorded with a custom-
ized database. The analysis of the exon 4 of the NOD2/
CARD15 gene was also performed on the DNA of 25
tuscanian controls.
Controls have been chosen between patients referred to
our centers in the 2010–2014 period with an history of
mechanical or functional joint pain and submitted to
DNA collection; these patients were age and sex-matched
and were use as historical control population. We selected
patients and controls of tuscanian ancestry, according to
family history reported, in order to guarante a common
genetic background.
DNA extraction and genotyping
Blood samples were collected in EDTA-containing tubes
during routine venipuncture. DNA was extracted using
the High Pure PCR Template Preparation kit (Roche
Applied Science, France), according to manufacturer’s
instructions. Genomic DNA was eluted in sterile water,
and stored at −20 °C; the concentration of the eluted gen-
omic DNA was determined by spectrophotometry with
the Nanodrop® ND-1000 (NanoDrop Technologies INC,
Wilmington, DE, USA). PCR reaction was conducted
using primers designed with the Primer3 software. Sam-
ples were amplified in a Eppendorf Mastercycler thermal
cycler and then the PCR products were purified using the
WizardSVGel and PCR Clean-up System (Promega). The
purification was applied to both PCR product and extracts
from agarose gel. The sequencing reaction was performed
with ABI 3730 DNA Analyzer (Applied Biosystems Life
Sciences Corporation, Carlsbad, CA, U.S.A.) and the
electropherogram analysis was performed through the
software Sequencher v.4.2.2 (GeneCodes, USA).
Statistical analysis
Allelic and genotypic frequencies (CC, CT, TT) in cases
and controls were calculated; then differences between
groups in terms of SNP variants frequencies were deter-
mined with chi-square test and Fisher exact test with
Monte Carlo simulations, when appropriate. Since the
number of subjects carrying a TT genotype was very low,
the analysis was performed also comparing frequency data
in two groups: those carrying at least one CARD 15 *T
allele and those carrying the CC genotype. The Spearman
rank correlation test was used to determine correlation
coefficients for different variables [gender, age at diagnosis,
uveitis duration, types of uveitis (granulomatous, and not-
granulomatous, anterior, posterior, pars-planitis, mono/bi-
lateral), ANA positivity, HLA-B27 presence, auto-immune
associated diseases, eye complications]. The odds ratio
(OR) and 95 % confidence interval (95 % CI) were calcu-
lated. Non-parametric tests were used, where necessary,
due to the small size of our groups and to the skewness of
our data. Levels of p < 0.05 were considered statistically
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significant. All analyses were performed on SPSS package
for Windows, version 13.0 (SPSS, Inc., Chicago, IL, USA).
Prevalence of NOD2/CARD15 variants
The P268S/SNP5 (SNP rs2066842) involves a C to T
change resulting in a P to S amino acid change; these
common variation of the NOD2/CARD15 gene have
been identified in 17 of our cases: 15 patients showed
the polymorphism P268S/SNP5 (SNP rs2066842) as het-
erozygous carriers while 2 patients were homozygous for
the same polymorphism. The polymorphism distribution
in AUC resulted as follows: 6/25 CC (24 %), 17/25 CT
(68 %), 2/25 TT (8 %) [Table 1]. One patient carried two
different mutations: the polymorphism P268S/SNP5 in
heterozygous and a variant on intron 3 (c647 18–16
TCT). We regarded the variation c647 as a non-
functional one and so we include this patient in the
same group as the heterozygous carriers of the P268S/
SNP5 polymorphism. The incidence of P268S/SNP5 in
our population was compared with the incidence re-
ported for 25 healthy historical controls, age and sex-
matched. According to genotype analysis, 14/25 controls
(56 %) did not present this polymorphism, 10/25 (40 %)
were heterozygous carrier and 1/25 (4 %) were homozy-
gous. No evidence of departure from Hardy-Weinberg
equilibrium in controls was seen (p = 0.65).
Statistical analysis for CARD 15 genotyping showed sig-
nificant differences between patients and controls for al-
lelic frequencies but not for genotypic frequencies. T allele
was present in 19/25 (76 %) AUC subjects compared to
11/25 (44 %) controls, and C allele in 23/25 (33.3 %)
(p = 0.04, OR: 4.03, 95 % CI = 1.2–13.5) [Table 2].
The functional role of the P268S/SNP5 (SNP rs2066842)
variant was predicted using SIFT (version 5.0.2) and Poly-
Phen (PolyPhen-2 version 2.2.2, release 405).
Genotype-phenotype correlation
Table 3 show the main characteristics of our cohort of
enrolled patients. We also tried to assess if the T allele
presence could impact the clinical course of the disease in
patients. We failed to show any association between one
genotype and the considered clinical variables. In particu-
lar, outcome of ACU was not modified by NOD2/CARD15
polymorphisms, since the incidence of macular edema,
synechiae, glaucoma, visual loss and cataract was not
increased in the group of patients heterozygous or homo-
zygous for P268S/SNP5 [Table 4].
Implications of the hypothesis
ACU appears as an heterogeneous group of disorders
resulting from a disregulation of both innate and adapta-
tive immune responses; the genetic bases of these condi-
tions appear to be extremely complex. The interesting
hypothesis that NOD2/CARD15 mutations can trigger
ocular inflammation has been suggested by several studies,
mostly carried out in animal models [9, 10]: in mice
NOD2 exerts a regulatory role on the inflammatory
process and may participate in the development of uveitis
in response to bacterial peptidoglycans. It has been shown
that in humans this association is more complex and not
fully understood; researchers' interest on this gene has
been evoked by the discovery that loss-of-function muta-
tions and gain-of-function mutations can be both identi-
fied in two different diseases, Crohn's disease and Blau
syndrome, showing non-caseating epithelioid granulomas
as prominent histopathological features.
In Blau syndrome mutations (mainly R334W, R334Q
and L469F) alter the NOD domain of the receptor and
exert a direct pathogenetic role, and uveitis is part of the
diagnostic triad; it is a distinctive granulomatous, both
anterior and posterior, and its prognosis in term of visual
loss is grim because it can evolve into a severe destructive
panuveitis and be responsible for permanent blindness. In
Crohn's disease mutations affecting the leucine-rich repeat
domain of the receptor confer to carriers an increased
susceptibility to the disease and chronic anterior uveitis is
an extra-intestinal feature of this condition.
The variant P268S/SNP5 (SNP rs2066842) involves a
C to T change resulting in a P to S amino acid change;
according to SIFT (version 5.0.2) and PolyPhen (Poly-
Phen-2 version 2.2.2, release 405) software software; pre-
dictions this variant appeared to be tolerated without
deleterious impact on protein function.
In our ACU population the variant P268S/SNP5 (SNP
rs2066842) was found in 17 over 25 patients; the preva-
lence of our variant was compared with the incidence
reported for 25 healthy historical controls, age and sex-
matched.
In contrast to previous reports [11, 12], our study,
showed a statistical association between the variant
Table 1 Comparison of CARD 15* genotype frequencies (%) in
Autoimmune Chronic Uveitis versus controls
Genotype Cases (n = 25)
CARD 15*TT 2 (8 %)
CARD 15*TC 17 (68 %)
CARD 15* CC 6 (24 %)
Values are the number (%) of the subjects tested
CARD 15* genotype comparison among controls and patients. (p = 0.06)
Table 2 A Comparison of CARD 15* C/T allele frequencies (%)
in Autoimmune Chronic Uveitis versus controls
Genotype Cases (n = 25)
CARD 15* T 19 (76 %)
CARD 15* C 6 (24 %)
Values are the number of subjects tested
CARD 15* T allele resulted more frequent in Autoimmune Chronic Uveitis than
in controls (*p = 0.04, OR: 4.03, 95 % CI = 1.2-13.5)
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P268S/SNP5 (SNP rs2066842) and ACU, both idiopathic
and associated with other rheumatic disease. In our
cohort the incidence of variations was not significantly
different between our patients with idiopathic chronic
uveitis and those with chronic uveitis associated to auto-
immune diseases.
However, our analysis failed to find any significant
association between CARD 15 mutation and type, clin-
ical course and outcome of our cohort of ACU.
Other studies trying to link NOD2 mutations and
non-infectious chronic uveitis failed to show any associ-
ation, with the remarkable exception of the Blau related
ones. In particular, Rodriguez-Perez and colleagues
[10, 11], in their cohort of more than 100 patients
with idiopathic chronic uveitis, reported allele fre-
quencies as high as 50 % for the variant P268S, 7 %
for the mutation R702W and 2 % for the mutation
G908R while none of the mutations responsible for
Blau syndrome (R334W, R334Q and L469F) was found
in any of the individuals tested. When the frequency
of the different mutations in the group of patients was
compared to that of 104 healthy subjects, no statistical
differences were found and the authors concluded that
none of the CARD15 mutations linked to Crohn's
Table 3 Demographical and medical characteristics of the studied population
Characteristics Pediatric Population (n = 18) Adult population (n = 7)
Age
Mean ± SD 11,8 ± 4,5 years 50 ± 22 years
Median (range) 11 (4 to 17 years) 53 (21 to 76 years)
Female gender, n (%) 12 (66 %) 5 (71 %)
Systemic disease association
None 8 2
Arthritis (JIA, Spondyloarthropathies, other forms) 10 2
Other / 3
Family history of autoimmune or inflammatory disease, n (%) 5 (27 %) 1 (14 %)
Uveitis
Age of onset
Mean ± SD 6,6 years ± 3 45 years ± 22
Median (range) 6,6 years (4 to 15 years) 50 (11 years to 74 years)
Duration
Mean ± SD 5,2 ± 4,4 years 4,9 ± 3,2 years
Median (range) 3,8 years 4,1 years
Table 4 Phenotype-genotype correlation
No mutation He Ho p-value
P268/SNP5 P268/SNP5
Comorbility, % (n) 5 9 50 % (1) n.s.
Positive family history, % (n) 1 4 50 % (1) n.s.
Granulomatous uveitis, % (n) 0 5 0 n.s.
Panuveitis, % (n) 3 9 0 n.s.
Bilateral uveitis, % (n) 6 8 50 % (1) n.s.
ANA positive, % (n) 3 7 50 % (1) n.s.
HLA B27 positive, % (n) 0 2 0 n.s.
Macular edema, % (n) 3 7 0 n.s.
Synechiae, % (n) 2 4 1 n.s.
Glaucoma, % (n) 2 2 0 n.s.
Visual loss, % (n) 2 3 0 n.s.
Cataract, % (n) 2 1 0 n.s.
He = heterozygous; Ho = homozygous n.s.
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Disease was involved in the pathogenesis of idiopathic
uveitis.
Our study enrolled only a limited cohort of patients
with ACU and we decided to adopt a case-control study
design; thus the statistic power of our study is to be con-
sidered limited. However we can't rule out a permissive
effect of the NOD2 common variant in the development
of uveitis.
This study was desgned as a pilot study; a study involv-
ing more patients affected with ACU is currently ongoing
in order to clarify if a different genetic background be-
tween cases as well a sample bias can explain this differ-
ence in P268S/SNP5 (SNP rs2066842) frequency between
the cases and controls.
However our healty controls showed an incidence
comparable with the data reported in the literature and




The variants c647 has not previously reported in the
literature and its role on gene's function is unknown.
Further functional analyses are needed in order to dis-
close its clinical significance.
To our knowledge, this is the first report demonstrating
a relationship between a NOD2 variants and eye inflam-
mation; nevertheless our analysis could not identify any
phenotype-genotype correlation. Moreover we could not
assess the influence of the genotype on the response to
pharmacological treatment because of the wide range of
therapies used in these patients. Further studies should
include a larger number of patients in order to identify the
genetic risks factors of non-infectious uveitis.
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